While GNAQ/11/14 mutations were identified with high frequency in patients with benign neoplasms, these gene mutations have not been reported in aggressive vascular tumors such as angiosarcoma or Kaposi’s sarcoma, suggesting hyperactive Gαq signaling in the endothelium does not participate in oncogenic transformation (33). This evidence concerns the gene GNAQ and vascular neoplasm.